International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 10-14 , April 2010

Fluctuations in glycosylated hemoglobin (HbA1C) as a predictor for the development of diabetic nephropathy in type 1 diabetic patients

  • Jocelyn Eid Fares

      Affiliations

    • Department of Internal Medicine, Division of Endocrinology, American University of Beirut-Medical Center, 3 Dag Hammarskjold Plaza – 8th Floor, New York, NY 10017 2324, USA
    • ,
  • Mona Kanaan

      Affiliations

    • Department of Epidemiology and Population Heath, American University of Beirut, USA
    • ,
  • Monique Chaaya

      Affiliations

    • Department of Epidemiology and Population Heath, American University of Beirut, USA
    • ,
  • Sami T. Azar

      Affiliations

    • Department of Internal Medicine, Division of Endocrinology, American University of Beirut-Medical Center, 3 Dag Hammarskjold Plaza – 8th Floor, New York, NY 10017 2324, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 961 3 234 250; fax: +1 961 1 365 189.

Received 28 October 2009 ,Revised 17 December 2009 ,Accepted 20 December 2009.

References 

  1. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex, duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39:1116–1124
  2. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, et al. Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care. 1989;12(10):686–693
  3. Newman DJ, Mattock MB, Dawnay AB, et al. Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess. 2005;9(30):iii–vixiii–163
  4. The DCCT. Research group: the effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  5. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24(7):1275–1279
  6. UKPDS GROUP . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  7. American Diabetes Association . Diabetic Nephropathy. Diabetes Care. 2003;26(S1):S94–S98
  8. ADA: Self monitoring of blood glucose (Consensus statement). Diabetes Care 1987; 10(1):95–99.
  9. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brwn DM, Goetz FC. Structural–functional relationships in diabetic nephropathy. J Clin Invest. 1984;74:1143–1155
  10. Twisk WRT. Applied longitudinal data analysis for Epidemiology: a practical guide, Cambridge University Press; 2003;
  11. Diggle PJ, Liang K, Zeger S. Analysis of longitudinal data, 2nd ed.. Oxford University Press; 2002;
  12. Raftery AE. Approximate Bays factors and accounting for model uncertainty in generalized linear models. Biometrika. 1996;83(2):251–266
  13. Long JS, Freese J. Regression models for categorical dependent variables using STATA, College Station (TX): Stata Press; 2001;
  14. D’Antonio JA, Ellis D, Doft BH, Becker DJ, Drash AL, Kuller LH, et al. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 years of IDDM. Diabetes Care. 1989;12(10):694–700
  15. Jones CA, Leese GP, Kerr S, Betswick K, Isherwood DI, Vora JP, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child. 1998;78:518–523
  16. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset and development of microvascular complications in childhood-onset type l diabetes. Diabetes Care. 2004;27(4):955–962
  17. Caramori MLA, Gross JL, Pecis M, Azevedo MJ. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow up study. Diabetes Care. 1999;22:1512–1516
  18. Holl RW, Grabert M, Thon A, Heinze E. Urinary excretion of albumin in adolescents with type 1 diabetes. Diabetes Care. 1999;22(9):1555–1560
  19. Drummond KN, Kramer MS, Suissa S, Levy-Marshal C, Dell’ Aniello S, Sinaiko Alan, et al. Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes. 2003;52(7):1818–1824
  20. Donaghue KC, Fairchild JM, Craig ME, Chan AK, Fracnzo SH, Cutler LR, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications?. Diabetes Care. 2003;26:1224–1229
  21. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;18:352;9123
  22. Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D, Gattuso P, et al. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes. 2005;54(7):2172–2178
  23. Hayashida T, Schnaper HW. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal-regulated kinase and protein kinase Cdelta activities in human mesangial cells. J Am Soc Nephrol. 2004;15(8):2032–2041
  24. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006;69(9):1654–1661
  25. Barzilay J, Warram J, Bak M, Laffel L, Canessa M, Krolewski A. Predisposition to hypertension: risk factor for nephropathy and hypertensionin IDDM. Kidney Int. 1992;41:723–730
  26. De Cosmo S, Bacci S, Piras G, Cignarelli M, Placentino G, Margaglione M, et al. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia. 1997;40:1191–1196
  27. Layne PH. Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol. 2002;283:F589–F600

PII: S1877-5934(09)00069-1

doi: 10.1016/j.ijdm.2009.12.012

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Pages 10-14 , April 2010

Article Tools